Novonesis A/S (LON:0Q4U)

Market Cap	22.94B
Revenue (ttm)	3.39B
Net Income (ttm)	383.57M
Shares Out	n/a
EPS (ttm)	1.32
PE Ratio	59.81
Forward PE	28.73
Dividend	0.70 (0.16%)
Ex-Dividend Date	Apr 4, 2025

Volume	16,289
Average Volume	451,579
Open	446.15
Previous Close	446.06
Day's Range	434.20 - 446.50
52-Week Range	38.30 - 60.79
Beta	0.56
RSI	64.14
Earnings Date	May 8, 2025

About Novonesis

Novonesis A/S produces and sells produces various industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as protein solutions and early lie nutrition. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and profe...

• Industry: Miscellaneous Chemical Products
• Founded: 1925
• Employees: 10,582
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0Q4U

Financial Performance

In 2024, Novonesis's revenue was 3.83 billion, an increase of 59.58% compared to the previous year's 2.40 billion. Earnings were 305.80 million, a decrease of -24.66%.

Financial numbers in EUR